Proventis Med
Reversible Implant for Long-Term Male Contraceptive Protection
Health Tech & Life Sciences
Private
Company Overview
Snapshot
Founded in January 2025 by Bar Evyatar and Netta Nir-Hirshberg, Proventis Med operates with 1–10 employees. The company secured its Pre-Seed funding round in September 2025.
Business overview
Proventis Med is a Health Tech & Life Sciences company focused on advancing reproductive health. The company is developing a long-term, reversible implant for male contraception, designed to offer reliable protection without daily attention. This implant can be minimally invasively placed by a physician and later deactivated to restore fertility. Proventis Med collaborates with urologists, medical experts, and investors to bring its solution to market.
Log in to access full profile ›Company Intelligence Q&A
- When was Proventis Med founded?
- Proventis Med was founded in January 2025.
- Who are the founders of Proventis Med?
- The co-founders of Proventis Med are Bar Evyatar, who serves as CEO, and Netta Nir-Hirshberg, who is the COO.
- What is Proventis Med developing?
- Proventis Med is developing a long-term, reversible implant for male contraceptive protection, intended to be placed by a physician and later deactivated to restore fertility.
- What is the primary sector of Proventis Med?
- Proventis Med operates within the Health Tech & Life Sciences sector.